Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 9Lung Neoplasms 3Uterine Cervical Neoplasms 2Neoplasms 2Motor Activity 2Colorectal Neoplasms 2Anxiety Disorders 2Sarcopenia 1Resectable Lung Non-Small Cell Carcinoma 1Psychological Well-Being 1Prostatic Neoplasms 1Postoperative Complications 1Parasomnias 1Panic Disorder 1Pancreatic Neoplasms 1Liver Neoplasms 1Fatigue 1Emotional Regulation 1Depression 1Colonic Neoplasms 1Caregivers With a Child Followed up With a Cancer Diagnosis 1Bile Duct Neoplasms 1

Interventions

Specimen Handling 2nedaplatin 1X-Rays 1Relaxation Therapy 1Protons 1Proton Therapy 1Platinum Compounds 1Physical Therapy Modalities 1Pemetrexed 1Paclitaxel 1Docetaxel 1Cisplatin 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Resectable Lung Non-Small Cell Carcinoma × Relaxation Therapy × Clear all
NCT07584239 2026-05-26

Prehabilitation Physical Therapy and Relaxation Intervention Program to Promote Resiliency and Operative Success Among Adults Receiving Lung Cancer Surgery, ROAR-LCS Trial

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
30 enrolled

Resectable Lung Non-Small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡